SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001493152-24-024182
Filing Date
2024-06-17
Accepted
2024-06-17 17:30:32
Documents
53

Document Format Files

Seq Description Document Type Size
1 forms-4a.htm   iXBRL S-4/A 6571604
2 ex23-1.htm EX-23.1 4271
3 ex23-2.htm EX-23.2 4139
4 forms-4a_001.jpg GRAPHIC 9814
5 forms-4a_002.jpg GRAPHIC 38231
6 forms-4a_003.jpg GRAPHIC 11875
7 forms-4a_004.jpg GRAPHIC 25023
8 annexg_001.jpg GRAPHIC 371478
9 annexg_002.jpg GRAPHIC 398762
10 annexg_003.jpg GRAPHIC 306021
  Complete submission text file 0001493152-24-024182.txt   14374293

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE tenk-20240331.xsd EX-101.SCH 31262
12 XBRL CALCULATION FILE tenk-20240331_cal.xml EX-101.CAL 30775
13 XBRL DEFINITION FILE tenk-20240331_def.xml EX-101.DEF 159713
14 XBRL LABEL FILE tenk-20240331_lab.xml EX-101.LAB 253153
15 XBRL PRESENTATION FILE tenk-20240331_pre.xml EX-101.PRE 218461
56 EXTRACTED XBRL INSTANCE DOCUMENT forms-4a_htm.xml XML 803697
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-275506 | Film No.: 241049439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)